Discover
SLNO
Soleno Therapeutics, Inc.
53.01
2 x 38.15
2 x 67.82
bid
ask
+
53.01
0.00%
2 @ 04:00 PM
52.99 -0.02 (0.04%)
| Ytd | 14.49% | |
| 1y | -29.33% |
52.98
day range
53.01
29.43
52 week range
90.32
| Open | 52.98 | Prev Close | Low | 52.98 | High | 53.01 | Mkt Cap | 2.76B | |
| Vol | 4.97M | Avg Vol | 3.62M | EPS | 1.93 | P/E | 27.47 | Forward P/E | -23.35 |
| Beta | -2.22 | Short Ratio | 1.01 | Inst. Own | 111.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 45.78 | 200-d Avg | 51.16 | 1yr Est | 53.00 |
| Income Statement | |||
| Total Revenue | 94.60M | ||
| Revenues (USD) | 94.60M | ||
| Cost of Revenue | 1.20M | ||
| Gross Profit | 93.41M | ||
| Operating Expenses | 61.64M | ||
| Research and Development Expense | 11.27M | ||
| Selling, General and Administrative Expense | 50.37M | ||
| Operating Income | 31.76M | ||
| Interest Expense | 1.29M | ||
| Income Tax Expense | 3.54M | ||
| Net Income | 31.38M | ||
| Net Income Common Stock | 31.38M | ||
| Net Income Common Stock (USD) | 31.38M | ||
| Consolidated Income | 31.38M | ||
| Earnings per Basic Share | 0.60 | ||
| Earnings per Basic Share (USD) | 0.60 | ||
| Earnings per Diluted Share | 0.59 | ||
| Earning Before Interest & Taxes (EBIT) | 36.21M | ||
| Earning Before Interest & Taxes (USD) | 36.21M | ||
| Preferred Dividends Income Statement Impact | 1000 | ||
| Weighted Average Shares | 52.09M | ||
| Weighted Average Shares Diluted | 53.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 133.03M | ||
| Cash and Equivalents (USD) | 133.03M | ||
| Investments | 395.96M | ||
| Investments Current | 122.57M | ||
| Investments Non-Current | 273.38M | ||
| Trade and Non-Trade Receivables | 47.14M | ||
| Current Assets | 326.38M | ||
| Property, Plant & Equipment Net | 4.09M | ||
| Total Assets | 608.39M | ||
| Debt Current | 1.16M | ||
| Total Debt | 54.28M | ||
| Current Liabilities | 58.05M | ||
| Debt Non-Current | 53.11M | ||
| Total Liabilities | 112.59M | ||
| Accumulated Retained Earnings (Deficit) | -399.99M | ||
| Accumulated Other Comprehensive Income | -1.84M | ||
| Shareholders Equity | 495.80M | ||
| Shareholders Equity (USD) | 495.80M | ||
| Assets Non-Current | 282.01M | ||
| Total Debt (USD) | 54.28M | ||
| Goodwill and Intangible Assets | 4.37M | ||
| Inventory | 17.31M | ||
| Liabilities Non-Current | 54.54M | ||
| Trade and Non-Trade Payables | 12.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 663.00K | ||
| Net Cash Flow from Financing | -1.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 62.92M | ||
| Capital Expenditure | -40.00K | ||
| Issuance (Purchase) of Equity Shares | 48.00K | ||
| Net Cash Flow from Investing | 37.98M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 38.02M | ||
| Net Cash Flow from Operations | 25.98M | ||
| Share Based Compensation | 16.06M | ||